Term
|
Definition
increase rxn rate by 10^11 or higher |
|
|
Term
|
Definition
suffix for enzyme
example: transferase, transfer functional group to another molecule |
|
|
Term
|
Definition
3D surface complementary to substrate
binds substrate, forms enzyme-substrate complex (ES)
doesnt change rxn equilibrium, complex forms enzyme-product complex (EP) |
|
|
Term
|
Definition
active, nonprotein component
apoenzyme is inactive
cofactors are metal (Zn, Fe) |
|
|
Term
|
Definition
small organic molecule
cosubstrate for transient association (NAD, CoA)
prosthetic groups also coenzymes but for permanent association (FAD,example) |
|
|
Term
|
Definition
different parts work in different environments (say in different pH's) so parts of enzyme still work when others don't |
|
|
Term
|
Definition
all rxns have energy barrier that separates reactants/products
must have enough energy overcome barrier to transition state, enzyme allows rxn to happen fast with lower activation energy.
does NOT change rxn equilibrium |
|
|
Term
Factors affecting rxn velocity |
|
Definition
substrate concentration, temp, pH
max velocity (saturation; Vmax), reached with increased substrate concentration
example- body enzyme optimal at 37 degrees, increase above this will denature enzymes |
|
|
Term
|
Definition
affects ionization of active site (acid base H exchange)
pH optimum varies, pepsin for example is pH 2 |
|
|
Term
|
Definition
assumes steady state, Vo, ES-complex
Km is affinity of enzyme for substrate, which is 1/2 Vmax
large Km is low affinity for substrate.
small Km s high affinity of enzyme for substrate
|
|
|
Term
|
Definition
converts to linear curve, not hyperbolic like MM eqn.
estimates exact Vmax, determine mechanism of action of enzyme inhibitors |
|
|
Term
|
Definition
increases apparent Km for substrate, Vmax is still unchanged though.
therefore decreasing enzyme affinity for substrate |
|
|
Term
Lipitor Competitive Inhibitor |
|
Definition
reduce cholesterol synthesase.
binds at active site of HM CoA reductase, to compete with HMG-CoA (which usually binds to form cholesterol) |
|
|
Term
Noncompetitive Inhibitors |
|
Definition
antagonist bound irreversible, binds at diff site to inhibit enzyme in noncompetitive way. No way to fight this
decreases Vmax, Km unchanged. competitive will change Km (not Vmax cause it can be beat) |
|
|
Term
|
Definition
alter Vmax and substrate concentration that will give half Vmax is altered. |
|
|
Term
Alanine Aminotransferase
(ALT) |
|
Definition
in plasma, signals possible damage to hepatic tissue
(enzyme in clinical dx) |
|
|
Term
|
Definition
dx of myocardial infarction
myocardial cell die (enzyme in clinical dx again) |
|
|